血清Hcy、FGF-23对H型高血压患者主要不良心脑血管事件的预测价值

doi:10.3969/j.issn.1671-7171.2023.04.021

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1170 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To explore the predictive value of serum homocysteine (Hcy) and fibroblast growth factor 23 (FGF-23) on major adverse cardiovascular and cerebrovascular events in patients with type H hypertension. 【Methods】 A total of 86 patients with H-type hypertension admitted to our hospital (observation group) were selected,and 78 healthy volunteers who came to the hospital for physical examination during the same period (control group) were selected. We compared the serum levels of Hcy and FGF-23 between patients with H-type hypertension and healthy individuals. The observation group was followed up for 1 year and divided into two groups based on the occurrence of major adverse cardiovascular and cerebrovascular events:the occurrence group (n=22) and the non-occurrence group (n=64). Univariate analysis of factors affecting the occurrence of major adverse cardiovascular and cerebrovascular events in patients with type H hypertension. Logistic regression analysis was conducted on the factors influencing the occurrence of major adverse cardiovascular and cerebrovascular events in patients with H-type hypertension. The value of predicting the occurrence of major adverse cardiovascular and cerebrovascular events in patients with H-type hypertension was analyzed using the receiver operating characteristic curve (ROC curve) to analyze serum Hcy and FGF-23 levels. 【Results】 The serum FGF-23 and Hcy levels in the observation group were higher than those in the control group,with statistically significant differences (P<0.05). Univariate analysis showed that the mean arterial pressure (MAP),left ventricular mass index (LVMI),low-density lipoprotein (LDL-C),and serum Hcy and FGF-23 levels in the affected group were higher than those in the non affected group (P<0.05). Logistic multivariate regression analysis showed that LDL-C,Hcy,and FGF-23 were independent risk factors for the occurrence of major adverse cardiovascular and cerebrovascular events in patients with type H hypertension (P<0.05). 【Conclusion】 Serum Hcy and FGF-23 levels are associated with the occurrence of major adverse cardiovascular and cerebrovascular events in patients with H-type hypertension,and their combination can serve as sensitive indicators for predicting the occurrence of major adverse cardiovascular and cerebrovascular events.

Key words： Hypertension Cysteine/BL Fibroblast Growth Factors/BL

Received: 18 April 2022

PACS:

R544.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XU Guo-ping
	REN Qian
	XIAO Hong-fang

Cite this article:

XU Guo-ping,REN Qian,XIAO Hong-fang. Predictive Value of Serum Hcy and FGF-23 for Major Adverse Cardiovascular and Cerebrovascular Events in Patients with H-type Hypertension[J]. JOURNAL OF CLINICAL RESEARCH, 2023, 40(4): 557-560.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2023.04.021 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2023/V40/I4/557

[1] 魏心源,蒋与刚,黄承钰,等. 中老年高血压人群H型高血压患病程度与认知功能关系分析[J].中国全科医学,2021,24(20):2520-2526.
[2] QIAN X L,CAO H,ZHANG J,et al. The prevalence,relative risk factors and MTHFR C677T genotype of H type hypertension of the elderly hypertensives in Shanghai,China:a cross-section study :Prevalence of H type hypertension [J].BMC Cardiovasc Disord,2021,21(1):376-382.
[3] PAUL S,WONG M,AKHABUE E,et al. Fibroblast growth factor 23 and incident cardiovascular disease and mortality in middle-aged adults [J].J Am Heart Assoc,2021,10(16):196-202.
[4] SINGH G.Fibroblast growth factor 23 level and cardiovascular parameters in children with chronic kidney disease [J].Indian J Pediatr,2021,91(1):87-93.
[5] 李建平,卢新政,霍勇,等. H型高血压诊断与治疗专家共识[J].中国实用内科杂志,2016,36(4):295-299.
[6] 何伋. 实用临床心脑血管病学[M]. 长春:吉林科学技术出版社,2014:96-97.
[7] LI T Y,LIU X,DIAO S S,et al. H-type hypertension is a risk factor for cerebral small-vessel disease[J].Biomed Res Int,2020,11(18):7899-7913.
[8] SHI Y M,DING C C,HU L H,et al. Saturation effects of plasma homocysteine on chronic kidney disease in Chinese adults with h-type hypertension:a cross-sectional study[J].J Ren Nutr,2021,31(5):459-466.
[9] 杜威,王栗莉,李曼. sST2、FGF-23、sCD40L对维持性血液透析患者心血管事件发生的预测价值[J].临床肾脏病杂志,2021,21(8):648-653.
[10] ZHANG Z Y,GU X,TANG Z,et al. Homocysteine,hypertension,and risks of cardiovascular events and all-cause death in the Chinese elderly population:a prospective study [J].J Geriatr Cardiol,2021,18(10):796-808.
[11] KONG Y L,LI X,CHANG L,et al. Hypertension with high homocysteine is associated with default network gray matter loss[J].Front Neurol,2021,108(4):439-451.
[12] SCHWANTES-AN T H.Fibroblast growth factor 23 genotype and cardiovascular disease in patients undergoing hemodialysis[J].Am J Nephrol,2019,49(2):125-132.
[13] 张秦风,高奋,王远,等. H型高血压病人Hcy水平、血压及冠状动脉病变程度的相关性研究[J].中西医结合心脑血管病杂志,2019,17(20):3155-3158.
[14] KAPLAN P,TATARKOVA Z,SIVONOVA M K,et al. Homocysteine and mitochondria in cardiovascular and cerebrovascular systems [J].Int J Mol Sci,2020,21(20):7698-7704.

[1]	. [J]. JOURNAL OF CLINICAL RESEARCH, 2023, 40(5): 771-773.